AB-161 is an orally bioavailable small molecule that destabilizes HBV RNA and inhibits PAPD5/7, primarily acting in the liver. It potently reduces hepatitis B surface antigen (HBsAg) levels with an EC50 of 2.2 nM and is used in research for investigating HBV infection, including in vitro and in vivo studies.
Molecular Weight:
433.41
CAS Number:
[2848560-66-5]
Formula:
C21H21F2N3O5
Target:
HBV
* VAT and and shipping costs not included. Errors and price changes excepted